IBB Innovations Revenue and Competitors
Estimated Revenue & Valuation
- IBB Innovations's estimated annual revenue is currently $4.3M per year.
- IBB Innovations's estimated revenue per employee is $116,000
Employee Data
- IBB Innovations has 37 Employees.
- IBB Innovations grew their employee count by 0% last year.
IBB Innovations's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Microsoft Dynamics 365 Practice | Reveal Email/Phone |
2 | Operations Manager | Reveal Email/Phone |
IBB Innovations Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $17.5M | 121 | 12% | N/A | N/A |
#2 | $90.4M | 499 | 24% | N/A | N/A |
#3 | $2M | 20 | -23% | N/A | N/A |
#4 | $226.8M | 1094 | 46% | $261M | N/A |
#5 | $406.7M | 2600 | 8% | $26.1M | N/A |
#6 | $14.8M | 102 | -61% | N/A | N/A |
#7 | $8.6M | 66 | -1% | N/A | N/A |
#8 | $13.2M | 91 | -5% | $752.5M | N/A |
#9 | $36.5M | 229 | 6% | N/A | N/A |
#10 | $56.6M | 312 | 23% | N/A | N/A |
What Is IBB Innovations?
IBB Innovations' strategy builds on our expertise in consulting and technology. Adding that to our industry knowledge and the industry specific solutions offering, we help businesses around the world to undertake high-impact business improvement projects.
keywords:N/A
N/A
Total Funding
37
Number of Employees
$4.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
IBB Innovations News
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) has been ... seeking capital-weighted exposure to innovative healthcare companies.
(NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today...
... prices and premiums for access to biotech innovations that they ... The largest of the biotech ETFs is iShares Biotechnology ETF (IBB),...
Other Companies in Dallas
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.5M | 37 | -5% | N/A |
#2 | $6.2M | 37 | -7% | N/A |
#3 | $9.8M | 37 | -7% | N/A |
#4 | $3.6M | 37 | 19% | N/A |
#5 | $6.2M | 37 | -7% | N/A |